Clinical trial
Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (GREENFIELD)
NCT01754129 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (GREENFIELD)
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- May 31, 2016
- Enrollment
- 148 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease